UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 20, 2016
LDR HOLDING CORPORATION
(Exact Name of Registrant as Specified in its Charter)
_____________________
DELAWARE (State or Other Jurisdiction of Incorporation) | 001-36095 (Commission File Number) | 20-3933262 (I.R.S. Employer Identification No.) |
13785 Research Boulevard, Suite 200 Austin, Texas 78750 (Address of Principal Executive Offices) | 78750 (Zip Code) | |
Registrant’s telephone number including area code: (512) 344-3333 | ||
No change since last report (Former Name or Address, if Changed Since Last Report) | ||
_____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 1 - Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On January 20, 2016, LDR Médical, S.A.S. (“LDR Médical”), a wholly-owned subsidiary of LDR Holding Corporation (the “Company”), entered into a new Supply Agreement (the “Agreement”) with Greatbatch Medical SA (“Greatbatch”) replacing its existing Supply Agreement with Greatbatch Medical SAS, dated November 28, 2012. The Agreement is effective December 31, 2015 and provides for the continued supply by Greatbatch of Mobi-C for an additional 5 years from January 1, 2016.
The Company intends to file the Agreement on a subsequent filing, and intends to seek confidential treatment for certain portions of the Agreement, including pricing and quantity terms at such time.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LDR HOLDING CORPORATION | |||
By: | /s/ Scott Way | ||
Name: | Scott Way | ||
Title: | Executive Vice President, General Counsel, Compliance Officer and Secretary | ||
Dated: January 20, 2016